|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.5800 USD | -7.26% |
|
+2.33% | -68.31% |
| 09-17 | Jasper Therapeutics, Inc.(NasdaqCM:JSPR) added to NASDAQ Composite Index | CI |
| 09-14 | Jasper Therapeutics, Inc. Appoints Lisa Pitt, Pharm.D., M.S.J. as Senior Vice President | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 19.3M | - | - | - | - | - |
| 74.46B | |||||
| 60.14B | |||||
| 48.15B | |||||
| 44.25B | |||||
| 43.99B | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
